News
ARAV
0.0401
0.00%
0.00
Weekly Report: what happened at ARAV last week (0226-0301)?
Weekly Report · 03/04 09:12
Weekly Report: what happened at ARAV last week (0219-0223)?
Weekly Report · 02/26 09:13
Weekly Report: what happened at ARAV last week (0212-0216)?
Weekly Report · 02/19 09:13
Weekly Report: what happened at ARAV last week (0205-0209)?
Weekly Report · 02/12 09:12
Weekly Report: what happened at ARAV last week (0129-0202)?
Weekly Report · 02/05 09:13
Aravive Inc: Amendments to 40 Act only filings
Press release · 01/29 23:02
Weekly Report: what happened at ARAV last week (0122-0126)?
Weekly Report · 01/29 09:12
12 Health Care Stocks Moving In Friday's Pre-Market Session
Inspire Veterinary (NASDAQ:IVP) stock moved upwards by 178.9% to $0.52 during Friday's pre-market session. Aclarion stock increased by 115.01% and Corbus Pharmaceuticals stock rose 25.48% during the same period. Losers include Jin Medical International and Onconetix.
Benzinga · 01/26 13:05
Why 3M Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of 3M Company dipped 12.5% to $94.54 on Tuesday. The company reported better-than-expected fourth-quarter EPS, but issued FY24 guidance below estimates. FaZe Holdings Inc. Shares climbed 63.6% after the company announced a new esports sponsorship deal. Chinese stocks traded higher following reports of a stock market rescue package.
Benzinga · 01/23 19:37
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Ensysce Biosciences stock moved upwards by 28.1% to $1.46 during Tuesday's pre-market session. Outlook Therapeutics (NASDAQ:OTLK) shares increased by 23.52%. Inovio Pharmaceuticals shares decreased by 20.5% during the session.
Benzinga · 01/23 13:06
Why United Airlines Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
United Airlines Holdings, Inc. Shares rose 6% in today's pre-market trading. The company reported better-than-expected financial results for its fourth quarter. United Airlines reported quarterly earnings of $2.00 per share and sales of $13.60 billion.
Benzinga · 01/23 12:55
Weekly Report: what happened at ARAV last week (0115-0119)?
Weekly Report · 01/22 09:13
Dow Surges Over 100 Points; M&T Bank Posts Weak Earnings
U.S. Stocks traded higher toward the end of trading on Thursday, with the Dow Jones index gaining more than 100 points. The Dow traded up 0.35% to 37,398.50 while the NASDAQ rose 1.16%. M&T Bank Corporation posted weaker-than-expected earnings for its fourth quarter on Thursday. Information technology shares rose by 2% on Thursday while health care shares dipped by 1.1%. European shares closed higher today while Asian markets closed mixed. In commodity news, oil traded up 2.2% to $74.17 while gold traded up 1.5%.
Benzinga · 01/18 19:25
Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
KeyCorp shares fell 5.4% to $13.10 after the company reported fourth-quarter financial results. Lytus Technologies Holdings PTV. Ltd. Shares jumped 92.8% after falling 5% on Wednesday. Agrify Corporation shares jumped 90% in Thursday's mid-day session.
Benzinga · 01/18 18:08
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Celularity (NASDAQ:CELU) shares moved upwards by 44.7% to $0.27 during Thursday's regular session. NovoCure shares increased by 24.15%. Jasper Therapeutics shares rose by 22.18%. Losers Aravive, Cano Health and MAIA Biotechnology.
Benzinga · 01/18 17:31
Crude Oil Rises Over 1%; Processa Pharmaceuticals Shares Slide
U.S. Stocks traded mostly higher midway through trading on Thursday. The Nasdaq Composite gained more than 1% while the Dow traded down 0.02%. Information technology shares rose by 2% on Thursday while health care shares dipped by 1.1%. The EIA said crude oil inventories in the U.s. Declined by 2.492 million barrels in the week ending Jan. 12.
Benzinga · 01/18 17:00
Nasdaq Jumps Over 100 Points; US Jobless Claims Fall To 187,000
The Dow traded down 0.33% to 37,143.30 while the NASDAQ rose 0.97% on Thursday. U.S. Stocks traded mixed on Thursday, with the Nasdaq Composite gaining more than 100 points. Information technology shares rose by 1.4% and health care shares dipped by 0.9% in Asian markets. Initial jobless claims fell by 16,000 to 187,000 in the week ending January 18.
Benzinga · 01/18 14:47
BUZZ-U.S. STOCKS ON THE MOVE-Apple, Humana, Birkenstock
The benchmark S&P 500 and the Nasdaq were set to open higher on Thursday. Apple, Humana, Birkenstock are among the top stocks on the NYSE and Nasdaq. The chip and megacap stocks are buoyed by strong results from Nvidia and Applied Materials.
Reuters · 01/18 14:23
Shell Layoffs 2024: What to Know About the Latest SHEL Job Cuts
Shell is following up on an internal announcement in December to reduce its headcount. The company is reportedly cutting 200 jobs in its Low Carbon Solutions division in 2024. Shell stock is down slightly as of Thursday morning. Nuvve, Marpai and Aravive are among the stocks moving today.
Investorplace · 01/18 14:18
More
Webull provides a variety of real-time ARAV stock news. You can receive the latest news about Aravive Inc through multiple platforms. This information may help you make smarter investment decisions.
About ARAV
Aravive, Inc. is a clinical-stage oncology company. The Company is focused on developing treatments designed to halt the progression of life-threatening diseases, including cancer and fibrosis. The Company's lead product candidate, Batiraxcept, is an ultra-high affinity decoy protein that binds to GAS6, the sole ligand that activates AXL, thereby inhibiting metastasis and tumor growth, and restoring sensitivity to anti-cancer agents. Batiraxcept has been granted Fast Track Designation by the United States Food and Drug Administration (FDA) for both clear cell renal cell carcinoma and platinum-resistant ovarian cancer and Orphan Drug Designation by the European Commission in platinum-resistant recurrent ovarian cancer. Batiraxcept is in an active registrational Phase III trial in platinum-resistant ovarian cancer (NCT04729608), a Phase Ib/II trial in clear cell renal cell carcinoma (NCT04300140), and a Phase Ib/II trial in pancreatic adenocarcinoma (NCT04983407).